Skip to content
Screener

Viatris VTRS Price / earnings

Price / earnings at other companies

Pfizer logo
PfizerPFE
14.7×—
McKesson logo
McKessonMCK
22.3×-3.3×
ANI Pharmaceuticals logo
ANI PharmaceuticalsANIP
18.7×—
Cencora logo
CencoraCOR
29.9×+6.0×
AMP
Amphastar PharmaceuticalsAMPH
11.2×+1.5×
ARS Pharmaceuticals, Inc. logo
ARS Pharmaceuticals, Inc.SPRY
128.2×—

Other financials

Income statement

See full
Revenue$3.5B+8.1%
Gross profit$1.2B-0.3%
Operating income-$79.7M+97.2%
Net income$176.4M+106%
EPS (diluted)$0.15+106%

Balance sheet

See full
Cash & equivalents$1.8B+139%
Total debt$14.6B+1.0%
Total equity$14.7B-6.3%
Total assets$36.8B-4.3%

Cash flow

See full
Operating cash flow$388.3M-27.5%
CapEx$39.9M-6.3%
Free cash flow$348.4M-29.3%

Valuation

See full
Market cap$20.45B+94.9%
Enterprise value$33.26B+34.7%
P/S1.4×+0.7×

Profitability

See full
Gross margin34.4%-2.5pp
Operating margin1%—
Net margin-2%-1.0pp
FCF margin12.3%-1.0pp

Returns & leverage

See full
Return on equity-2%-0.9pp
Debt / equity1×+0.1×
Current ratio1.6×-0.1×

Where this comes from

Calculated from Viatris’s reported figures.

market cap/net income=6.5×

Based on the most recent quarter.

The source filing: Viatris’s 10-Q, filed November 7, 2024. Open the filing →

Filed
Nov 7, 2024
Fiscal quarter
Q3 FY2024
Calendar quarter
Q3 2024
Accession
0001792044-24-000033

FAQ

What is Viatris's price / earnings?
Viatris (VTRS) reported price / earnings of 6.5× in Q3 2023.
How has Viatris's price / earnings changed year-over-year?
Viatris's price / earnings decreased by 49.8% year-over-year, from 12.9× to 6.5×.
What does price / earnings mean?
Market capitalization at the quarter end divided by trailing-twelve-month net income. The price the market pays for each dollar of trailing earnings.

Ask your AI about Viatris's price / earnings.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude